Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

RGC – Regencell Bioscience Holdings Ltd

RGC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.62

Margin Of Safety %

Put/Call OI Ratio

1.06

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

4.91

Target Price

Analyst Recom

Performance Q

-7.66

Upside

-105.3%

Beta

1.75

Ticker: RGC




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15RGC9.41.310.376634
2026-10-16RGC9.631.030.918856
2026-10-19RGC10.092.141.404758
2026-10-20RGC10.361.462.254309
2026-10-21RGC10.871.670.124441
2026-10-22RGC9.851.630.054503
2026-10-23RGC7.611.730.014406
2026-10-26RGC6.751.640.064499
2026-10-27RGC7.451.520.024637
2026-10-28RGC7.331.560.004590
2026-10-29RGC6.831.420.004761
2026-10-30RGC6.611.400.004794
2026-11-02RGC6.251.410.004786
2026-11-03RGC6.19381.410.004787
2026-11-04RGC5.391.400.254788
2026-11-05RGC5.271.371.674801
2026-11-06RGC5.321.3829.004818
2026-11-09RGC5.5951.012.374111
2026-11-10RGC5.241.0395.004160
2026-11-11RGC5.421.080.954254
2026-11-12RGC5.141.070.054312
2026-11-13RGC5.021.060.064318
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15RGC9.36- - -
2026-10-16RGC9.61- - -
2026-10-19RGC10.10- - -
2026-10-20RGC10.10- - -
2026-10-21RGC10.41- - -
2026-10-22RGC9.85- - -
2026-10-23RGC7.61- - -
2026-10-26RGC6.78- - -
2026-10-27RGC7.41- - -
2026-10-28RGC7.20- - -
2026-10-29RGC6.85- - -
2026-10-30RGC6.66- - -
2026-11-02RGC6.27- - -
2026-11-03RGC6.11- - -
2026-11-04RGC5.41- - -
2026-11-05RGC5.26- - -
2026-11-06RGC5.32- - -
2026-11-09RGC5.62- - -
2026-11-10RGC5.24- - -
2026-11-11RGC5.45- - -
2026-11-12RGC5.16- - -
2026-11-13RGC4.91- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-15RGC0.0063.321.17
2026-10-16RGC0.0063.321.17
2026-10-19RGC0.0063.321.17
2026-10-20RGC0.0063.321.17
2026-10-21RGC0.0063.321.17
2026-10-22RGC0.0063.321.17
2026-10-23RGC0.0063.321.17
2026-10-26RGC0.0063.291.17
2026-10-27RGC0.0063.290.78
2026-10-28RGC0.0063.290.78
2026-10-29RGC0.0063.290.78
2026-10-30RGC0.0063.290.78
2026-11-02RGC0.0064.450.78
2026-11-03RGC0.0064.450.78
2026-11-05RGC0.0064.450.78
2026-11-06RGC0.0064.450.78
2026-11-09RGC0.0063.180.78
2026-11-10RGC0.0063.180.78
2026-11-11RGC0.0063.180.62
2026-11-12RGC0.0063.180.62
2026-11-13RGC0.0063.180.62
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

63.18

Beta

1.75

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

8

Growth Score

Sentiment Score

24

Actual DrawDown %

94.1

Max Drawdown 5-Year %

-93.9

Target Price

P/E

Forward P/E

PEG

P/S

P/B

183.51

P/Free Cash Flow

EPS

-0.02

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.49

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-94.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ RGC Healthcare
$4.94
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
18/20
Pullback
15/25
Volume
11/15
Valuation
6/20
TP/AR
2/10
Options
1/10
RSI
34.5
Range 1M
2.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
21 /100
WEAK
Momentum
7/25
Growth
4/30
Estimates
0/20
Inst/Vol
5/15
Options
5/10
EPS Yr
0%
EPS NY
0%
52W%
0.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
Quality
2/30
Valuation
2/30
Growth
0/25
Stability
7/10
LT Trend
4/5
Quality
8
RGC — P/E HistoricalDrug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings L
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 10
Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
RGC

Latest News

—
Caricamento notizie per RGC…
stock quote shares RGC – Regencell Bioscience Holdings Ltd Stock Price stock today
news today RGC – Regencell Bioscience Holdings Ltd stock forecast ,stock prediction 2023 2024 2025
marketwatch RGC – Regencell Bioscience Holdings Ltd yahoo finance google finance
stock history RGC – Regencell Bioscience Holdings Ltd invest stock market
stock prices RGC premarket after hours
ticker RGC fair value insiders trading

SIMO – Silicon Motion Technology Corporation

SIMO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

5.2

Margin Of Safety %

Put/Call OI Ratio

0.33

EPS Next Q Diff

2.59

EPS Last/This Y

-0.57

EPS This/Next Y

7.92

Price

169.36

Target Price

360.7

Analyst Recom

1.08

Performance Q

-37.86

Upside

91.9%

Beta

1.78

Ticker: SIMO




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15SIMO218.280.410.3725161
2026-10-16SIMO211.140.400.1625781
2026-10-19SIMO217.470.400.0618127
2026-10-20SIMO214.180.370.4519840
2026-10-21SIMO222.510.370.7819905
2026-10-22SIMO187.860.380.4620008
2026-10-23SIMO187.30.380.7221322
2026-10-26SIMO188.490.380.0621661
2026-10-27SIMO204.170.330.3824454
2026-10-28SIMO220.520.330.1524706
2026-10-29SIMO227.020.320.1527424
2026-10-30SIMO208.450.300.6029605
2026-11-02SIMO187.860.311.4329867
2026-11-03SIMO201.670.350.1431272
2026-11-04SIMO182.570.340.4831646
2026-11-05SIMO155.930.350.5932897
2026-11-06SIMO162.70.330.4733401
2026-11-09SIMO171.840.330.2133822
2026-11-10SIMO1690.330.2234301
2026-11-11SIMO183.780.320.9434712
2026-11-12SIMO179.380.330.4934850
2026-11-13SIMO169.320.330.1035118
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15SIMO218.32233.3- 11.14
2026-10-16SIMO211.27233.3- 11.14
2026-10-19SIMO217.68233.3- 11.14
2026-10-20SIMO217.68233.3- 11.14
2026-10-21SIMO213.56233.3- 11.14
2026-10-22SIMO187.96233.3- 11.14
2026-10-23SIMO187.34233.3- 11.14
2026-10-26SIMO188.94233.3- 11.14
2026-10-27SIMO204.09233.3- 11.14
2026-10-28SIMO220.63233.3- 11.14
2026-10-29SIMO227.62233.3- 11.14
2026-10-30SIMO208.89233.3- 11.14
2026-11-02SIMO187.86315.6- 13.60
2026-11-03SIMO201.73308.2- 13.62
2026-11-04SIMO182.64310.0- 13.63
2026-11-05SIMO155.99310.0- 13.63
2026-11-06SIMO162.88310.0- 13.63
2026-11-09SIMO171.90310.0- 13.63
2026-11-10SIMO169.19310.0- 13.63
2026-11-11SIMO183.65310.0- 13.63
2026-11-12SIMO179.32310.0- 13.63
2026-11-13SIMO169.36310.0- 13.63
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-15SIMO-2.70-6.704.55
2026-10-16SIMO-2.70-6.704.55
2026-10-19SIMO-2.70-5.814.55
2026-10-20SIMO-2.82-5.814.55
2026-10-21SIMO-2.82-5.814.55
2026-10-22SIMO-2.82-5.814.55
2026-10-23SIMO-2.82-5.814.55
2026-10-26SIMO-2.82-5.684.55
2026-10-27SIMO-2.82-5.684.99
2026-10-28SIMO-2.82-5.684.99
2026-10-29SIMO-2.82-5.684.99
2026-10-30SIMO-2.82-5.684.99
2026-11-02SIMO-2.82-4.884.99
2026-11-03SIMO-2.82-4.884.99
2026-11-05SIMO-2.82-4.884.99
2026-11-06SIMO-2.82-4.884.99
2026-11-09SIMO-2.19-6.494.99
2026-11-10SIMO-2.19-6.494.99
2026-11-11SIMO-2.19-6.495.20
2026-11-12SIMO-2.19-6.495.20
2026-11-13SIMO-2.19-6.495.20
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

1.91

Avg. EPS Est. Current Quarter

5.17

Avg. EPS Est. Next Quarter

4.5

Insider Transactions

-2.19

Institutional Transactions

-6.49

Beta

1.78

Average Sales Estimate Current Quarter

604

Average Sales Estimate Next Quarter

580

Fair Value

Quality Score

66

Growth Score

100

Sentiment Score

68

Actual DrawDown %

52.3

Max Drawdown 5-Year %

-56.5

Target Price

360.7

P/E

18.23

Forward P/E

8.22

PEG

0.09

P/S

3.52

P/B

6.89

P/Free Cash Flow

EPS

9.29

Average EPS Est. Cur. Y​

13.63

EPS Next Y. (Est.)

21.55

Target Price Estimates Raised

Target Price Estimates Lowered

1

Profit Margin

19.36

Relative Volume

0.81

Return on Equity vs Sector %

-26.5

Return on Equity vs Industry %

-32.8

EPS 1 7Days Diff

2.5

EPS 1 30Days Diff

2.49

EBIT Estimation

◆ SIMO Technology
$169.45
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
15/25
Volume
4/15
Valuation
15/20
TP/AR
4/10
Options
6/10
RSI
38.7
Range 1M
15.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
57 /100
WATCH
Momentum
13/25
Growth
26/30
Estimates
7/20
Inst/Vol
1/15
Options
10/10
EPS Yr
279.8%
EPS NY
52.9%
52W%
32.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +278.8% upside
Quality
19/30
Valuation
19/30
Growth
20/25
Stability
8/10
LT Trend
3/5
Upside
+278.8%
Quality
66
SIMO — P/E HistoricalSemiconductors
Silicon Motion Technology Corpo
Sector: Technology
Industry: Semiconductors
Employees: 2009
Silicon Motion Technology Corporation, together with its subsidiaries, designs, develops, and markets NAND flash controllers for solid-state storage devices and related devices in China, Japan, Singapore, Taiwan, Korea, the United States, and internationally. It offers controllers for computing-grade solid state drives (SSDs), which are used in PCs and other client devices; enterprise-grade SSDs used in enterprise and hyperscale data centers; eMMC and UFS mobile embedded storage for use in smartphones and IoT devices; flash memory cards and flash drives for use in expandable storage; and specialized SSDs that are used in industrial, commercial, and automotive applications. The company markets its controllers under the SMI brand; and single-chip SSDs under the FerriSSD, Ferri-eMMC, and Ferri-UFS brands. It markets and sells its products through direct sales personnel and independent electronics distributors to NAND flash makers, module makers, hyperscalers, and OEMs. Silicon Motion Technology Corporation was founded in 1995 and is based in Hong Kong, Hong Kong.
SIMO

Latest News

—
Caricamento notizie per SIMO…
stock quote shares SIMO – Silicon Motion Technology Corporation Stock Price stock today
news today SIMO – Silicon Motion Technology Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch SIMO – Silicon Motion Technology Corporation yahoo finance google finance
stock history SIMO – Silicon Motion Technology Corporation invest stock market
stock prices SIMO premarket after hours
ticker SIMO fair value insiders trading

NHTC – Natural Health Trends Corp.

NHTC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.61

Margin Of Safety %

Put/Call OI Ratio

11.62

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.75

Target Price

Analyst Recom

Performance Q

-56.66

Upside

-360.0%

Beta

1.02

Ticker: NHTC




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15NHTC0.93021.30999.99283
2026-10-16NHTC0.971.8029.50345
2026-10-19NHTC0.9453.05999.99466
2026-10-20NHTC0.92274.28999.99607
2026-10-21NHTC0.84995.15999.99707
2026-10-22NHTC0.8175.63999.99762
2026-10-23NHTC0.85.69999.99769
2026-10-26NHTC0.895.77999.99779
2026-10-27NHTC0.8916.47999.99859
2026-10-28NHTC0.87568.17999.991054
2026-10-29NHTC0.78328.3733.101078
2026-10-30NHTC0.76558.75999.991219
2026-11-02NHTC0.7810.30999.991413
2026-11-03NHTC0.882711.14999.991518
2026-11-04NHTC0.83111.7916.901599
2026-11-05NHTC0.830211.19999.991646
2026-11-06NHTC0.760311.58999.991698
2026-11-09NHTC0.752411.58999.991698
2026-11-10NHTC0.739911.61999.991703
2026-11-11NHTC0.790211.62999.991704
2026-11-12NHTC0.738511.62999.991704
2026-11-13NHTC0.749411.62999.991704
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15NHTC0.94- - -
2026-10-16NHTC0.96- - -
2026-10-19NHTC0.94- - -
2026-10-20NHTC0.94- - -
2026-10-21NHTC0.90- - -
2026-10-22NHTC0.83- - -
2026-10-23NHTC0.78- - -
2026-10-26NHTC0.88- - -
2026-10-27NHTC0.88- - -
2026-10-28NHTC0.83- - -
2026-10-29NHTC0.79- - -
2026-10-30NHTC0.76- - -
2026-11-02NHTC0.78- - -
2026-11-03NHTC0.87- - -
2026-11-04NHTC0.83- - -
2026-11-05NHTC0.85- - -
2026-11-06NHTC0.76- - -
2026-11-09NHTC0.74- - -
2026-11-10NHTC0.73- - -
2026-11-11NHTC0.79- - -
2026-11-12NHTC0.73- - -
2026-11-13NHTC0.75- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-15NHTC0.00-1.340.16
2026-10-16NHTC0.00-1.340.16
2026-10-19NHTC0.00-1.300.16
2026-10-20NHTC0.00-1.300.16
2026-10-21NHTC0.00-1.300.16
2026-10-22NHTC0.00-1.300.16
2026-10-23NHTC0.00-1.300.16
2026-10-26NHTC0.00-1.390.16
2026-10-27NHTC0.00-1.390.56
2026-10-28NHTC0.00-1.390.56
2026-10-29NHTC0.00-1.390.56
2026-10-30NHTC0.00-1.390.56
2026-11-02NHTC0.00-1.400.56
2026-11-03NHTC0.00-1.400.56
2026-11-05NHTC0.00-1.400.56
2026-11-06NHTC0.00-1.400.56
2026-11-09NHTC0.00-1.490.56
2026-11-10NHTC0.00-1.490.56
2026-11-11NHTC0.00-1.490.61
2026-11-12NHTC0.00-1.490.61
2026-11-13NHTC0.00-1.490.61
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-1.49

Beta

1.02

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

43

Growth Score

25

Sentiment Score

23

Actual DrawDown %

90.8

Max Drawdown 5-Year %

-91.1

Target Price

P/E

Forward P/E

PEG

P/S

0.19

P/B

0.42

P/Free Cash Flow

EPS

-0.15

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-4.18

Relative Volume

0.69

Return on Equity vs Sector %

-29.7

Return on Equity vs Industry %

-31.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ NHTC Consumer Cyclical
$0.75
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
19/25
Volume
9/15
Valuation
6/20
TP/AR
2/10
Options
0/10
RSI
38.6
Range 1M
17.9%
Sup Dist
7.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
9 /100
WEAK
Momentum
0/25
Growth
8/30
Estimates
1/20
Inst/Vol
0/15
Options
0/10
EPS Yr
0%
EPS NY
0%
52W%
1.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
Quality
6/30
Valuation
2/30
Growth
3/25
Stability
7/10
LT Trend
1/5
Quality
43
NHTC — P/E HistoricalInternet Retail
Natural Health Trends Corp.
Sector: Consumer Cyclical
Industry: Internet Retail
Employees: 118
Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, such as liquid, encapsulated, tableted and powder dietary and nutritional supplements, vitamins, and minerals; and herbal products, including herbal supplements. It also provides beauty products comprising facial skin care, hand and body care, age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products consisting of weight management and energy enhancing supplements, as well as topical gels. In addition, the company offers at-home testing kits for measuring critical biomarkers of well-being, including cardiovascular, hormonal, inflammatory, metabolic, and nutritional health. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, the Cayman Islands, Mexico, Peru, and Colombia; Hong Kong, Taiwan, and China; Malaysia and Singapore; South Korea; Russia and Kazakhstan; Japan; India; and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Rolling Hills Estates, California.
NHTC

Latest News

—
Caricamento notizie per NHTC…
stock quote shares NHTC – Natural Health Trends Corp. Stock Price stock today
news today NHTC – Natural Health Trends Corp. stock forecast ,stock prediction 2023 2024 2025
marketwatch NHTC – Natural Health Trends Corp. yahoo finance google finance
stock history NHTC – Natural Health Trends Corp. invest stock market
stock prices NHTC premarket after hours
ticker NHTC fair value insiders trading

MSC – Studio City International Holdings Ltd ADR

MSC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.01

Margin Of Safety %

46

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.99

Target Price

13.65

Analyst Recom

4

Performance Q

-45.76

Upside

-415.2%

Beta

0.11

Ticker: MSC




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15MSC0.994N/AN/A0
2026-10-16MSC0.975N/AN/A0
2026-10-19MSC0.904N/AN/A0
2026-10-20MSC0.845N/AN/A0
2026-10-21MSC0.835N/AN/A0
2026-10-22MSC0.8N/AN/A0
2026-10-23MSC0.7907N/AN/A0
2026-10-26MSC0.79N/AN/A0
2026-10-27MSC0.8N/AN/A0
2026-10-28MSC0.7906N/AN/A0
2026-10-29MSC0.8N/AN/A0
2026-10-30MSC0.8N/AN/A0
2026-11-02MSC0.9784N/AN/A0
2026-11-03MSC1.055N/AN/A0
2026-11-04MSC0.8635N/AN/A0
2026-11-05MSC1.09N/AN/A0
2026-11-06MSC0.95N/AN/A0
2026-11-09MSC0.9522N/AN/A0
2026-11-10MSC0.92N/AN/A0
2026-11-11MSC1.01N/AN/A0
2026-11-12MSC0.9925N/AN/A0
2026-11-13MSC0.9373N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15MSC0.96- - -
2026-10-16MSC0.98- - -
2026-10-19MSC0.93- - -
2026-10-20MSC0.93- - -
2026-10-21MSC0.85- - -
2026-10-22MSC0.78- - -
2026-10-23MSC0.80- - -
2026-10-26MSC0.79- - -
2026-10-27MSC0.80- - -
2026-10-28MSC0.78- - -
2026-10-29MSC0.81- - -
2026-10-30MSC0.78- - -
2026-11-02MSC0.94- - -
2026-11-03MSC1.05- - -
2026-11-04MSC0.90- - -
2026-11-05MSC1.08- - -
2026-11-06MSC0.92- - -
2026-11-09MSC0.99- - -
2026-11-10MSC0.96- - -
2026-11-11MSC1.01- - -
2026-11-12MSC0.99- - -
2026-11-13MSC0.99- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-15MSC0-0.000.00
2026-10-16MSC0-0.000.00
2026-10-19MSC0-0.000.00
2026-10-20MSC0-0.000.00
2026-10-21MSC0-0.000.00
2026-10-22MSC0-0.000.00
2026-10-23MSC0-0.000.00
2026-10-26MSC0-0.000.00
2026-10-27MSC0-0.000.02
2026-10-28MSC0-0.000.02
2026-10-29MSC0-0.000.02
2026-10-30MSC0-0.000.02
2026-11-02MSC0-0.000.02
2026-11-03MSC0-0.000.02
2026-11-05MSC0-0.000.02
2026-11-06MSC0-0.000.02
2026-11-09MSC0-0.000.02
2026-11-10MSC0-0.000.02
2026-11-11MSC0-0.000.01
2026-11-12MSC0-0.000.01
2026-11-13MSC0-0.000.01
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

0.11

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

1.44

Quality Score

53

Growth Score

52

Sentiment Score

53

Actual DrawDown %

89.7

Max Drawdown 5-Year %

-91.3

Target Price

13.65

P/E

Forward P/E

PEG

P/S

0.29

P/B

0.44

P/Free Cash Flow

EPS

-0.24

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.97

Relative Volume

1.12

Return on Equity vs Sector %

-29.2

Return on Equity vs Industry %

-35.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ MSC Consumer Cyclical
$0.99
📉
Swing / Pullback
Buy the dip on strong trends
42 /100
WEAK
Trend
10/20
Pullback
11/25
Volume
4/15
Valuation
15/20
TP/AR
2/10
Options
0/10
RSI
51.6
Range 1M
47.3%
Sup Dist
9.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
14 /100
WEAK
Momentum
4/25
Growth
4/30
Estimates
4/20
Inst/Vol
2/15
Options
0/10
EPS Yr
0%
EPS NY
0%
52W%
7.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +538.8% upside
Quality
5/30
Valuation
23/30
Growth
4/25
Stability
1/10
LT Trend
2/5
Upside
+538.8%
Quality
53
MoS
46%
MSC — P/E HistoricalResorts & Casinos
Studio City International Holdi
Sector: Consumer Cyclical
Industry: Resorts & Casinos
Employees: 5879
Studio City International Holdings Limited provides provision of services pursuant to a casino contract and the hospitality business in Macau. It operates gaming services, a casino contract for the operation of studio city casino, focusing on mass market and premium mass market table games and gaming machines, including baccarat, three-card baccarat, blackjack, craps, caribbean stud poker, roulette, sic bo, fortune 3 card poker, and other games; hospitality services; dining services; event and convention services; other services; leasing services; and resort, which offers various non-gaming attractions, including figure-8 ferris wheel, nightclub and karaoke venue, live performance arena, and an outdoor and indoor water park, as well as live performance arena and various food and beverage establishments, and retail space. The company was formerly known as Cyber One Agents Limited and changed its name to Studio City International Holdings Limited in January 2012. The company was founded in 2000 and is based in Central, Hong Kong. Studio City International Holdings Limited is a subsidiary of MCO Cotai Investments Limited.
MSC

Latest News

—
Caricamento notizie per MSC…
stock quote shares MSC – Studio City International Holdings Ltd ADR Stock Price stock today
news today MSC – Studio City International Holdings Ltd ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch MSC – Studio City International Holdings Ltd ADR yahoo finance google finance
stock history MSC – Studio City International Holdings Ltd ADR invest stock market
stock prices MSC premarket after hours
ticker MSC fair value insiders trading

FUTU – Futu Holdings Limited

FUTU — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

6.2

Margin Of Safety %

29

Put/Call OI Ratio

1.12

EPS Next Q Diff

EPS Last/This Y

-0.48

EPS This/Next Y

2.53

Price

95.71

Target Price

147.9

Analyst Recom

1.38

Performance Q

Upside

N/A

Beta

0.42

Ticker: FUTU




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15FUTU110.21.251.3595921
2026-10-16FUTU105.471.242.2296927
2026-10-19FUTU105.551.280.7181275
2026-10-20FUTU105.551.260.8682883
2026-10-21FUTU1051.261.6483247
2026-10-22FUTU98.961.273.9284470
2026-10-23FUTU99.191.250.6484798
2026-10-26FUTU101.281.270.2882856
2026-10-27FUTU102.311.230.9784101
2026-10-28FUTU101.891.221.9684574
2026-10-29FUTU101.441.220.7885878
2026-10-30FUTU98.521.191.4285981
2026-11-02FUTU103.171.240.4483283
2026-11-03FUTU102.611.181.2686779
2026-11-04FUTU97.941.171.3387236
2026-11-05FUTU94.371.172.2387991
2026-11-06FUTU98.061.170.4790706
2026-11-09FUTU100.971.180.4187216
2026-11-10FUTU95.471.170.4988309
2026-11-11FUTU98.031.160.8189725
2026-11-12FUTU95.71.150.9990236
2026-11-13FUTU95.751.120.7590611
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15FUTU109.8227.9- 77.63
2026-10-16FUTU105.4627.9- 77.63
2026-10-19FUTU105.5527.9- 77.63
2026-10-20FUTU105.5527.9- 77.63
2026-10-21FUTU105.5527.9- 77.63
2026-10-22FUTU98.9627.9- 77.63
2026-10-23FUTU99.2127.9- 77.63
2026-10-26FUTU101.3227.9- 77.63
2026-10-27FUTU102.3427.9- 77.63
2026-10-28FUTU101.8827.9- 77.63
2026-10-29FUTU101.4327.9- 77.63
2026-10-30FUTU98.4827.9- 9.89
2026-11-02FUTU103.1827.9- 9.89
2026-11-03FUTU102.5327.9- 9.89
2026-11-04FUTU97.8027.9- 9.90
2026-11-05FUTU93.9927.9- 77.63
2026-11-06FUTU98.0227.9- 77.63
2026-11-09FUTU101.0527.9- 9.90
2026-11-10FUTU95.4627.9- 9.90
2026-11-11FUTU98.0427.9- 9.90
2026-11-12FUTU95.6427.9- 9.89
2026-11-13FUTU95.7127.9- 9.90
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

3.82

Avg. EPS Est. Next Quarter

3.76

Insider Transactions

Institutional Transactions

-1.74

Beta

0.42

Average Sales Estimate Current Quarter

851

Average Sales Estimate Next Quarter

812

Fair Value

123.19

Quality Score

80

Growth Score

97

Sentiment Score

40

Actual DrawDown %

52.7

Max Drawdown 5-Year %

-60.2

Target Price

147.9

P/E

11.56

Forward P/E

9.09

PEG

1

P/S

3.27

P/B

2.81

P/Free Cash Flow

EPS

9.1

Average EPS Est. Cur. Y​

9.9

EPS Next Y. (Est.)

12.42

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

41.84

Relative Volume

0.14

Return on Equity vs Sector %

16.2

Return on Equity vs Industry %

11.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

FUTU — P/E HistoricalCapital Markets
Futu Holdings Limited
Sector: Financial Services
Industry: Capital Markets
Employees: 3540
Futu Holdings Limited engages in the provision of digitalized securities brokerage and wealth management product distribution service in Hong Kong and internationally. It offers online financial services, including securities and derivative trades brokerage, margin financing and fund distribution services through its Futubull and Moomoo digital platforms. The company also provides financial information and online community services; online wealth management services under the Money Plus brand name through its Futubull and moomoo platforms, which provides its client access to mutual funds, private funds, bonds, structured products, and other wealth management products; market data and information services; and NiuNiu Community, an open forum for users and clients to share insights, ask questions, and exchange ideas. Futu Holdings Limited was founded in 2007 and is headquartered in Admiralty, Hong Kong.
FUTU

Latest News

—
Caricamento notizie per FUTU…
stock quote shares FUTU – Futu Holdings Limited Stock Price stock today
news today FUTU – Futu Holdings Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch FUTU – Futu Holdings Limited yahoo finance google finance
stock history FUTU – Futu Holdings Limited invest stock market
stock prices FUTU premarket after hours
ticker FUTU fair value insiders trading

HCM – HUTCHMED (China) Limited

HCM — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.16

Margin Of Safety %

-27

Put/Call OI Ratio

0.77

EPS Next Q Diff

EPS Last/This Y

-2.43

EPS This/Next Y

0.04

Price

14.9

Target Price

20.95

Analyst Recom

1.21

Performance Q

18.63

Upside

-76.5%

Beta

0.32

Ticker: HCM




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15HCM13.90.730.00197
2026-10-16HCM14.130.730.00197
2026-10-19HCM14.160.750.00185
2026-10-20HCM14.710.760.70185
2026-10-21HCM14.420.76999.99202
2026-10-22HCM14.220.770.04203
2026-10-23HCM14.410.77999.99204
2026-10-26HCM14.330.77999.99204
2026-10-27HCM13.850.780.00205
2026-10-28HCM13.30.780.00205
2026-10-29HCM13.60.780.00205
2026-10-30HCM13.20.780.00206
2026-11-02HCM13.290.780.00205
2026-11-03HCM13.030.780.00205
2026-11-04HCM13.880.780.00205
2026-11-05HCM14.2550.78999.99205
2026-11-06HCM15.180.78999.99205
2026-11-09HCM15.370.78999.99205
2026-11-10HCM15.3350.78999.99205
2026-11-11HCM15.10.771.00203
2026-11-12HCM14.920.771.00203
2026-11-13HCM14.980.771.00203
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15HCM13.94- 52.20.22
2026-10-16HCM14.14- 51.80.22
2026-10-19HCM14.15- 51.10.22
2026-10-20HCM14.15- 51.10.22
2026-10-21HCM14.80- 53.00.22
2026-10-22HCM14.27- 51.90.22
2026-10-23HCM14.41- 51.90.22
2026-10-26HCM14.29- 51.20.22
2026-10-27HCM13.85- 50.30.22
2026-10-28HCM13.33- 47.60.22
2026-10-29HCM13.63- 50.80.22
2026-10-30HCM13.19- 48.20.22
2026-11-02HCM13.30- 49.10.22
2026-11-03HCM13.11- 47.80.22
2026-11-04HCM13.92- 51.10.22
2026-11-05HCM14.15- 50.20.22
2026-11-06HCM15.21- 52.90.22
2026-11-09HCM15.32- 51.20.22
2026-11-10HCM15.37- 52.70.22
2026-11-11HCM15.04- 52.80.22
2026-11-12HCM14.93- 53.50.22
2026-11-13HCM14.90- 52.90.22
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-15HCM0.00-1.440.16
2026-10-16HCM0.00-1.440.16
2026-10-19HCM0.00-1.620.16
2026-10-20HCM0.00-1.620.16
2026-10-21HCM0.00-1.620.16
2026-10-22HCM0.00-1.620.16
2026-10-23HCM0.00-1.620.16
2026-10-26HCM0.001.410.16
2026-10-27HCM0.001.410.16
2026-10-28HCM0.001.410.16
2026-10-29HCM0.001.410.16
2026-10-30HCM0.001.410.16
2026-11-02HCM0.001.550.16
2026-11-03HCM0.001.550.16
2026-11-05HCM0.001.550.16
2026-11-06HCM0.001.550.16
2026-11-09HCM0.001.430.16
2026-11-10HCM0.001.430.16
2026-11-11HCM0.001.430.16
2026-11-12HCM0.001.430.16
2026-11-13HCM0.001.430.16
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

1.43

Beta

0.32

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

10.89

Quality Score

46

Growth Score

36

Sentiment Score

98

Actual DrawDown %

59

Max Drawdown 5-Year %

-78.5

Target Price

20.95

P/E

146.51

Forward P/E

31.02

PEG

P/S

4.72

P/B

2.06

P/Free Cash Flow

261.53

EPS

0.1

Average EPS Est. Cur. Y​

0.22

EPS Next Y. (Est.)

0.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.26

Relative Volume

0.33

Return on Equity vs Sector %

-25

Return on Equity vs Industry %

-5.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.06

EBIT Estimation

52.9
◆ HCM Healthcare
$14.90
📉
Swing / Pullback
Buy the dip on strong trends
39 /100
WEAK
Trend
0/20
Pullback
10/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
4/10
RSI
58.1
Range 1M
78.5%
Sup Dist
0.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
27 /100
WEAK
Momentum
5/25
Growth
13/30
Estimates
1/20
Inst/Vol
5/15
Options
3/10
EPS Yr
-85.6%
EPS NY
27.9%
52W%
79%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -19.4% upside
Quality
5/30
Valuation
2/30
Growth
8/25
Stability
7/10
LT Trend
1/5
Upside
-19.4%
Quality
46
MoS
-27%
HCM — P/E HistoricalDrug Manufacturers - General
HUTCHMED (China) Limited
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 1790
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. It provides Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to treat pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
HCM

Latest News

—
Caricamento notizie per HCM…
stock quote shares HCM – HUTCHMED (China) Limited Stock Price stock today
news today HCM – HUTCHMED (China) Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch HCM – HUTCHMED (China) Limited yahoo finance google finance
stock history HCM – HUTCHMED (China) Limited invest stock market
stock prices HCM premarket after hours
ticker HCM fair value insiders trading
No more stocks to show